GLP-3 / Tesa / Cagri
GLP-3 / Tesa / Cagri, 10mg / 5mg / 2.5mg. A triple-receptor incretin, a GHRH analog and an amylin analog. 99%+ HPLC, COA per lot. Research use only.
Select Vial Specification:- ISO/IEC 17025 independent lab tested (HPLC & Mass Spectrometry)
- Scannable QR code on every vial linking directly to lot COA
- Complimentary MBP-H2O reconstitution water included
- Same-day tracked dispatch on orders placed before 2:00 PM EST
Research Description
This is a blend. GLP-3, Tesamorelin and Cagri are combined in a single 17.5 mg vial at 10 mg, 5 mg and 2.5 mg respectively. It places a triple-receptor incretin compound, a growth-hormone-releasing-hormone analog and an amylin analog in one vial. The three are characterised separately in the literature; the combination has not been characterised as a single entity.
Agonism at the GIP, GLP-1 and glucagon receptors is characterised, with energy-expenditure and hepatic-lipid endpoints measured alongside the incretin readouts.
Tesamorelin is a GHRH analog studied for pulsatile growth-hormone release and downstream IGF-1 measures in GH-axis research.
Storage & Handling Protocol
Store lyophilized vials at −20 °C for long-term stability (up to 24 months) or 2–8 °C for short-term laboratory protocols. Protect from direct light and moisture. Strictly for in-vitro laboratory research use only.
Quality & Lot Specifications
| Compound | GLP-3 / Tesa / Cagri |
| Category | Peptide Blends |
| Lot Number | MBP-6440 → |
| Purity (RP-HPLC) | ≥ 99.0% (Verified) |
| Identity | Confirmed via ESI-MS |
| Endotoxin Screen | < 0.5 EU/mg (LAL Assay) |
| Physical Form | Lyophilized powder (No fillers) |
| Storage Temp | −20 °C Long-Term |
Customer Reviews
No reviews yet — click '+ Write a Review' to share your experience!